Milestone Scientific (NYSE:MLSS) Stock Price Up 0.9% – What’s Next?

Milestone Scientific Inc. (NYSE:MLSS)’s share price rose 0.9% during trading on Wednesday . The stock traded as high as $1.20 and last traded at $1.17. Approximately 57,443 shares traded hands during trading, a decline of 72% from the average daily volume of 202,214 shares. The stock had previously closed at $1.16.

Analyst Ratings Changes

MLSS has been the topic of several analyst reports. StockNews.com initiated coverage on Milestone Scientific in a report on Wednesday, January 29th. They set a “hold” rating on the stock. Benchmark reaffirmed a “speculative buy” rating and set a $1.25 target price on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

The firm has a fifty day simple moving average of $1.09 and a 200 day simple moving average of $0.96. The company has a market capitalization of $91.13 million, a price-to-earnings ratio of -16.71 and a beta of 1.14.

Institutional Trading of Milestone Scientific

Several institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC grew its holdings in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Carnegie Investment Counsel grew its holdings in Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares during the period. Renaissance Technologies LLC grew its holdings in Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after purchasing an additional 53,198 shares during the period. World Investment Advisors LLC acquired a new stake in Milestone Scientific in the third quarter valued at approximately $91,000. Finally, Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific in the third quarter valued at approximately $48,000. 5.79% of the stock is owned by institutional investors and hedge funds.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.